Provenance du réseau au premier degré de George Esgro
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada.
18
| Subsidiary | Pharmaceuticals: Major | 18 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.
17
| Subsidiary | Pharmaceuticals: Major | 17 |
Cornerstone BioPharma, Inc.
 Cornerstone BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone BioPharma, Inc. develops and commercializes biopharmaceutical products for respiratory disorders. Its products include AlleRx, Balacet, Deconsal, and Spectracef. The company was founded in March 2004 by Craig A. Collard, Chenyqua Baldwin, and Steven Lutz and is headquartered in Cary, NC
8
| Extinct | Pharmaceuticals: Major | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à George Esgro via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| CORNERSTONE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Director of Finance/CFO Founder Director of Finance/CFO | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Director/Board Member Director/Board Member | |
| University of Connecticut | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman Director of Finance/CFO Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Graduate Degree | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
Cedilla Therapeutics, Inc.
 Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chief Executive Officer | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Eli Lilly Canada, Inc.
 Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Canada, Inc. is a healthcare leader that focuses on oncology, diabetes, autoimmunity, neurodegeneration, and pain. The company is based in Scarborough, Canada. Established in 1938, the Canadian company collaborates with scientists to produce innovative medicines that make life better for people around the world. The company's mission is to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to communities through philanthropy and volunteerism. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Biovail Pharmaceuticals LLC
 Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Biovail Pharmaceuticals, Inc. researches and develops pharmaceutical medicines. The company products include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| University of Montréal | College/University | Graduate Degree Doctorate Degree | |
| PLIANT THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
GHO Capital Partners LLP
 GHO Capital Partners LLP Investment ManagersFinance GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
NinePoint Medical, Inc.
 NinePoint Medical, Inc. Medical SpecialtiesHealth Technology NinePoint Medical, Inc. develops and manufactures medical devices. It designs, manufactures, and sells an Optical Coherence Tomography (OCT) imaging platform for clinical use in gastroenterology, pulmonology, urology, gynecology, evaluation of human tissue microstructure. The company is headquartered in Bedford, MA. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
| JOUNCE THERAPEUTICS, INC. | Miscellaneous Commercial Services | President Chief Tech/Sci/R&D Officer | |
| Harvard Business School | College/University | Masters Business Admin Graduate Degree | |
| The University of North Carolina at Charlotte | College/University | Masters Business Admin Graduate Degree | |
| Tufts University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| McGill University | College/University | Graduate Degree Undergraduate Degree | |
| University of Wisconsin | College/University | Doctorate Degree Undergraduate Degree | |
| Babson College | College/University | Undergraduate Degree Masters Business Admin | |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| New York University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| University of Leeds | College/University | Doctorate Degree Graduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
NeRRe Therapeutics Ltd.
 NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Medical Distributors | Director/Board Member | |
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member | |
New England Venture Capital Association, Inc.
 New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member | |
Flexplay Technologies, Inc.
 Flexplay Technologies, Inc. Electronics/AppliancesConsumer Durables FlexPlay Technologies, Inc. designs disposable DVDs to work in various DVD players, DVD drives, and gaming systems. Its DVD is a '48-hour, no-return' DVD that enables time-limited, on-demand viewing. The company was co-founded by Yannis Bakos & Erik Brynjolfsson in 1999 and is based in Atlanta, GA | Electronics/Appliances | Chief Executive Officer | |
KaNDy Therapeutics Ltd.
 KaNDy Therapeutics Ltd. BiotechnologyHealth Technology KaNDy Therapeutics Ltd. engages in the provision of a treatment of chronic debilitating female sex-hormone related conditions. Its product is NT-814 a non-hormonal therapy to treat moderate to severe post-menopausal vasomotor symptoms. The company was founded by Dr. Mike Trower and Mary Kerr in 2017 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Chairman | |
| HP INC. | Computer Processing Hardware | Corporate Officer/Principal | |
| Coridea NC2, Inc. | Director/Board Member | ||
Cibiem, Inc.
 Cibiem, Inc. Medical SpecialtiesHealth Technology Cibiem, Inc. operates as a medical device company. Its catheter-based approach focuses on carotid body modulation for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes, and renal failure. The company was founded by Mark Gelfand and Howard R. Levin and is headquartered in Los Altos, CA. | Medical Specialties | Director/Board Member | |
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | Director/Board Member | |
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Pharmaceuticals: Major | Founder |
Statistiques
Internationale
| Etats-Unis | 37 |
| Royaume-Uni | 6 |
| Canada | 4 |
| Allemagne | 2 |
| Japon | 2 |
Sectorielle
| Health Technology | 28 |
| Consumer Services | 12 |
| Commercial Services | 5 |
| Finance | 4 |
| Process Industries | 2 |
Opérationnelle
| Director/Board Member | 177 |
| Corporate Officer/Principal | 136 |
| Independent Dir/Board Member | 53 |
| President | 49 |
| Chairman | 47 |
Relations les plus connectées
| Insiders | |
|---|---|
| Tadataka Yamada | 36 |
| Jim Datin | 34 |
| Neil Exter | 33 |
| Iain Dukes | 32 |
| Mark Levin | 26 |
| Paul Lucas | 24 |
| Michael Heffernan | 23 |
| Kimberlee Drapkin | 23 |
| Deborah Dunsire | 20 |
| Robert Friel | 16 |
| Bruce A. Leicher | 16 |
| Brian Dickson | 15 |
| David J. Price | 14 |
| Christopher George Codeanne | 14 |
| David W Miller | 14 |
- Bourse
- Insiders
- George Esgro
- Connexions Sociétés
